Yiran Cai

Effective Codelivery of lncRNA and pDNA by Pullulan‐Based Nanovectors for Promising Therapy of Hepatocellular Carcinoma

Yanli Ren, Rui‐Quan Li, Yiran Cai et al. · Advanced Functional Materials · 2016 · 63 citations

Nanotherapeutics, Effective Codelivery, Engineering +20

Clinical Characteristics and Outcomes of Patients with Primary Lung Adenocarcinoma Harboring ALK Rearrangements Detected by FISH, IHC, and RT-PCR

Jinghui Wang, Yiran Cai, Yujie Dong et al. · PLoS ONE · 2014 · 58 citations · Full text

Tumor Biology, Ventana Ihc, Medicine +14

Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification

Yujie Dong, Yiran Cai, LI-JUAN ZHOU et al. · Oncology Letters · 2016 · 40 citations · Full text

Kras Mutations, Invasive Lac, Somatic Variant +14

Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status

Jinghui Wang, Yujie Dong, Yiran Cai et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 38 citations · Full text

Primary Lung Adenocarcinoma, Medicine, Pathology +8

Chaperonin containing TCP1 subunit 5 is a tumor associated antigen of non-small cell lung cancer

Hongjun Gao, Min Zheng, Sijin Sun et al. · Oncotarget · 2017 · 30 citations · Full text

Immunology, Nsclc Tissues, Pathology +18